Release Date: 18/02/14 08:38 Summary: Half Year Accounts - Presentation Briefing Slides Price Sensitive: No Download Document 794.63KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%